INFOGRAPHIC: Which treatment to choose in the 1st line for a patient with type 2 diabetes?
Diabetes mellitus is a complex chronic disease that requires continuous treatment and a strategy to reduce associated risks beyond mere glycemic control. Comorbidities and the risk of complications are key elements in deciding the choice of therapy for type 2 diabetics. This fact is also considered by the American Diabetes Association (ADA) in its annually published standards of care for patients with diabetes, which brought several changes in 2022.
In the 1st line of treatment according to the current ADA recommendations, it is now advised to consider initiating glucagon-like peptide-1 receptor agonists (GLP-1RA) or sodium-glucose cotransporter 2 inhibitors (SGLT2i, i.e., gliflozins) in all patients with diabetes mellitus and risk of atherosclerosis, heart failure, or chronic kidney disease, regardless of the use of metformin. Recommendations for the pharmacotherapy of hyperglycemia in adults with type 2 diabetes are available in the form of a comprehensive algorithm, the Czech translation of which is provided in the following infographic.
The infographic can be downloaded as a PDF.
Did you like this article? Would you like to comment on it? Write to us. We are interested in your opinion. We will not publish it, but we will gladly answer you.